N-Nitroso Edoxaban Desmethyl Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Edoxaban is used to prevent stroke and blood clots in patients with a certain heart rhythm problem (eg, nonvalvular atrial fibrillation). Edoxaban is also used to treat deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs . N-Nitroso Edoxaban Desmethyl Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Edoxaban Desmethyl Impurity chemically represented as N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5- nitroso-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2- carboxamido)cyclohexyl)oxalamid .Synchemia is the leading manufacturing and exporter of N-Nitroso Edoxaban Desmethyl Impurity. We supply N-Nitroso Edoxaban Desmethyl Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142259 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142260 |
| CAS No | NA |
| Mol.F. | C14H17Br2N3O2 |
| Mol.Wt. | 419.12 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142261 |
| CAS No | NA |
| Mol.F. | C13H18BrN3O2 |
| Mol.Wt. | 328.21 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142262 |
| CAS No | NA |
| Mol.F. | C26H36Br2N4O4 |
| Mol.Wt. | 628.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142263 |
| CAS No | NA |
| Mol.F. | C26H36Br2N4O4 |
| Mol.Wt. | 628.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142264 |
| CAS No | NA |
| Mol.F. | C16H21Br2N3O4 |
| Mol.Wt. | 479.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142265 |
| CAS No | NA |
| Mol.F. | C16H21Br2N3O4 |
| Mol.Wt. | 479.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142266 |
| CAS No | NA |
| Mol.F. | C15H19Br2N3O4 |
| Mol.Wt. | 465.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142267 |
| CAS No | NA |
| Mol.F. | C15H19Br2N3O4 |
| Mol.Wt. | 465.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142268 |
| CAS No | NA |
| Mol.F. | C16H21Br2N3O4 |
| Mol.Wt. | 479.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142269 |
| CAS No | NA |
| Mol.F. | C11H14N2O2 |
| Mol.Wt. | 206 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142270 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.17 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142271 |
| CAS No | NA |
| Mol.F. | C23H26N2O4 |
| Mol.Wt. | 394.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142272 |
| CAS No | NA |
| Mol.F. | C23H25IN2O4 |
| Mol.Wt. | 520.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142273 |
| CAS No | NA |
| Mol.F. | C24H26I2N2O5 |
| Mol.Wt. | 676.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142274 |
| CAS No | NA |
| Mol.F. | C4H9ClN2O |
| Mol.Wt. | 136.58 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |